Valentino Stella

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Concepts & Ideas

Phenomena

Procedures

Occupations

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Tongiani Serena; Ozeki Tetsuya; Stella Valentino J
Sulfobutyl ether-alkyl ether mixed cyclodextrin derivatives with enhanced inclusion ability.
Sotthivirat Sutthilug; Haslam John L; Lee Ping I; Rao Venkatramana M; Stella Valentino J
Release mechanisms of a sparingly water-soluble drug from controlled porosity-osmotic pump pellets using sulfobutylether-beta-cyclodextrin as both a solubilizing and osmotic agent.
Dhareshwar Sundeep S; Stella Valentino J
Breakdown kinetics of C-hydroxymethyl beta-dicarbonyl derivatives of carbon acids: implications in the bioconversion rate of C-phosphoryloxymethyl prodrugs of carbon acids.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Valentino Stella (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Tongiani Serena; Ozeki Tetsuya; Stella Valentino J
Sulfobutyl ether-alkyl ether mixed cyclodextrin derivatives with enhanced inclusion ability.
Journal of pharmaceutical sciences 2009;98(12):4769-80.
2009: Sotthivirat Sutthilug; Haslam John L; Lee Ping I; Rao Venkatramana M; Stella Valentino J
Release mechanisms of a sparingly water-soluble drug from controlled porosity-osmotic pump pellets using sulfobutylether-beta-cyclodextrin as both a solubilizing and osmotic agent.
Journal of pharmaceutical sciences 2009;98(6):1992-2000.
2009: Dhareshwar Sundeep S; Stella Valentino J
Breakdown kinetics of C-hydroxymethyl beta-dicarbonyl derivatives of carbon acids: implications in the bioconversion rate of C-phosphoryloxymethyl prodrugs of carbon acids.
Journal of pharmaceutical sciences 2009;98(5):1804-12.
2008: Dhareshwar Sundeep S; Stella Valentino J
Your prodrug releases formaldehyde: should you be concerned? No!
Journal of pharmaceutical sciences 2008;97(10):4184-93.
2008: Tian Jiaher; Stella Valentino J
Degradation of paclitaxel and related compounds in aqueous solutions II: Nonepimerization degradation under neutral to basic pH conditions.
Journal of pharmaceutical sciences 2008;97(8):3100-8.
2008: Tian Jiaher; Stella Valentino J
Degradation of paclitaxel and related compounds in aqueous solutions I: epimerization.
Journal of pharmaceutical sciences 2008;97(3):1224-35.
2008: Stella Valentino J; He Quanren
Cyclodextrins.
Toxicologic pathology 2008;36(1):30-42.
2007: Hemenway Jeffrey N; Nti-Addae Kwame; Guarino Victor R; Stella Valentino J
Preparation, characterization and in vivo conversion of new water-soluble sulfenamide prodrugs of carbamazepine.
Bioorganic & medicinal chemistry letters 2007;17(23):6629-32.
2007: Guarino Victor R; Karunaratne Veranja; Stella Valentino J
Sulfenamides as prodrugs of NH-acidic compounds: a new prodrug option for the amide bond.
Bioorganic & medicinal chemistry letters 2007;17(17):4910-3.
2007: Sotthivirat Sutthilug; Haslam John L; Stella Valentino J
Controlled porosity-osmotic pump pellets of a poorly water-soluble drug using sulfobutylether-beta-cyclodextrin, (SBE) 7M-beta-CD, as a solubilizing and osmotic agent.
Journal of pharmaceutical sciences 2007;96(9):2364-74.
2007: Denora Nunzio; Potts Barbara C M; Stella Valentino J
A mechanistic and kinetic study of the beta-lactone hydrolysis of Salinosporamide A (NPI-0052), a novel proteasome inhibitor.
Journal of pharmaceutical sciences 2007;96(8):2037-47.
2007: Stella Valentino J; Nti-Addae Kwame W
Prodrug strategies to overcome poor water solubility.
Advanced drug delivery reviews 2007;59(7):677-94.
2007: Sotthivirat S; Lubach J W; Haslam J L; Munson E J; Stella V J
Characterization of prednisolone in controlled porosity osmotic pump pellets using solid-state NMR spectroscopy.
Journal of pharmaceutical sciences 2007;96(5):1008-17.
2007: Sotthivirat S; Haslam J L; Stella V J
Evaluation of various properties of alternative salt forms of sulfobutylether-beta-cyclodextrin, (SBE)7M-beta-CD.
International journal of pharmaceutics 2007;330(1-2):73-81.
2005: Tongiani Serena; Velde David Vander; Ozeki Tetsuya; Stella Valentino J
Sulfoalkyl ether-alkyl ether cyclodextrin derivatives, their synthesis, NMR characterization, and binding of 6alpha-methylprednisolone.
Journal of pharmaceutical sciences 2005;94(11):2380-92.
2005: Larsen Kim L; Aachmann Finn L; Wimmer Reinhard; Stella Valentino J; Kjølner Ulrich Madsen
Phase solubility and structure of the inclusion complexes of prednisolone and 6 alpha-methyl prednisolone with various cyclodextrins.
Journal of pharmaceutical sciences 2005;94(3):507-15.
2004: Jumaa M; Carlson B; Chimilio L; Silchenko S; Stella V J
Kinetics and mechanism of degradation of epothilone-D: an experimental anticancer agent.
Journal of pharmaceutical sciences 2004;93(12):2953-61.
2004: Okimoto Kazuto; Tokunaga Yuji; Ibuki Rinta; Irie Tetsumi; Uekama Kaneto; Rajewski Roger A; Stella Valentino J
Applicability of (SBE)7m-beta-CD in controlled-porosity osmotic pump tablets (OPTs).
International journal of pharmaceutics 2004;286(1-2):81-8.
2004: Jumaa M; Chimilio L; Chinnaswamy S; Silchenko S; Stella V J
Degradation of NSC-281612 (4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde), an experimental antineoplastic agent: effects of pH, solvent composition, (SBE)7m-beta-CD, and HP-beta-CD on stability.
Journal of pharmaceutical sciences 2004;93(3):532-9.
2003: Silchenko S; Schöneich C; Carlson B J; Stella V J
Photostability of 2-hydroxymethyl-4,8-dibenzo[1,2-b:5,4-b']dithiophene-4,8-dione (NSC 656240), a potential anticancer drug.
International journal of pharmaceutics 2003;264(1-2):97-105.
2003: Hanson Bradley A; Schowen Richard L; Stella Valentino J
A mechanistic and kinetic study of the E-ring hydrolysis and lactonization of a novel phosphoryloxymethyl prodrug of camptothecin.
Pharmaceutical research 2003;20(7):1031-8.
2003: Rao Venkatramana M; Stella Valentino J
When can cyclodextrins be considered for solubilization purposes?
Journal of pharmaceutical sciences 2003;92(5):927-32.
2001: Zannou E A; Streng W H; Stella V J
Osmotic properties of sulfobutylether and hydroxypropyl cyclodextrins.
Pharmaceutical research 2001;18(8):1226-31.
2001: Rao V M; Haslam J L; Stella V J
Controlled and complete release of a model poorly water-soluble drug, prednisolone, from hydroxypropyl methylcellulose matrix tablets using (SBE)(7m)-beta-cyclodextrin as a solubilizing agent.
Journal of pharmaceutical sciences 2001;90(7):807-16.
2001: Zia V; Rajewski R A; Stella V J
Effect of cyclodextrin charge on complexation of neutral and charged substrates: comparison of (SBE)7M-beta-CD to HP-beta-CD.
Pharmaceutical research 2001;18(5):667-73.
2001: Sakaeda T; Tada Y; Sugawara T; Ryu T; Hirose F; Yoshikawa T; Hirano K; Kupczyk-Subotkowska L; Siahaan T J; Audus K L; Stella V J
Conjugation with L-Glutamate for in vivo brain drug delivery.
Journal of drug targeting 2001;9(1):23-37.
2000: Zia V; Rajewski R A; Stella V J
Thermodynamics of binding of neutral molecules to sulfobutyl ether beta-cyclodextrins (SBE-beta-CDs): the effect of total degree of substitution.
Pharmaceutical research 2000;17(8):936-41.
2000: Wu S; Waugh W; Stella V J
Degradation pathways of a peptide boronic acid derivative, 2-Pyz-(CO)-Phe-Leu-B(OH)(2).
Journal of pharmaceutical sciences 2000;89(6):758-65.
2000: Antipas A S; Vander Velde D G; Jois S D; Siahaan T; Stella V J
Effect of conformation on the rate of deamidation of vancomycin in aqueous solutions.
Journal of pharmaceutical sciences 2000;89(6):742-50.
2000: Ma D Q; Rajewski R A; Vander Velde D; Stella V J
Comparative effects of (SBE)7m-beta-CD and HP-beta-CD on the stability of two anti-neoplastic agents, melphalan and carmustine.
Journal of pharmaceutical sciences 2000;89(2):275-87.
2000: Jarho P; Vander Velde D; Stella V J
Cyclodextrin-catalyzed deacetylation of spironolactone is pH and cyclodextrin dependent.
Journal of pharmaceutical sciences 2000;89(2):241-9.
2000: Sakaeda T; Siahaan T J; Audus K L; Stella V J
Enhancement of transport of D-melphalan analogue by conjugation with L-glutamate across bovine brain microvessel endothelial cell monolayers.
Journal of drug targeting 2000;8(3):195-204.
1999: Ma D Q; Rajewski R A; Stella V J
New injectable melphalan formulations utilizing (SBE)(7m)-beta-CD or HP-beta-CD.
International journal of pharmaceutics 1999;189(2):227-34.
1999: Krise J P; Charman W N; Charman S A; Stella V J
A novel prodrug approach for tertiary amines. 3. In vivo evaluation of two N-phosphonooxymethyl prodrugs in rats and dogs.
Journal of pharmaceutical sciences 1999;88(9):928-32.
1999: Krise J P; Narisawa S; Stella V J
A novel prodrug approach for tertiary amines. 2. Physicochemical and in vitro enzymatic evaluation of selected N-phosphonooxymethyl prodrugs.
Journal of pharmaceutical sciences 1999;88(9):922-7.
1999: Simon L D; Stella V J; Charman W N; Charman S A
Mechanisms controlling diffusion and release of model proteins through and from partially esterified hyaluronic acid membranes.
Journal of controlled release : official journal of the Controlled Release Society 1999;61(3):267-79.
1999: Simon L D; Stella V J; Charman W N; Charman S A
Variation in the diffusion and release of ribonuclease through and from esterified hyaluronic acid membranes: effect of changes in matrix characteristics.
Journal of controlled release : official journal of the Controlled Release Society 1999;61(1-2):159-64.
1999: Krise J P; Zygmunt J; Georg G I; Stella V J
Novel prodrug approach for tertiary amines: synthesis and preliminary evaluation of N-phosphonooxymethyl prodrugs.
Journal of medicinal chemistry 1999;42(16):3094-100.
1999: Stella V J; Martodihardjo S; Rao V M
Aqueous solubility and dissolution rate does not adequately predict in vivo performance: a probe utilizing some N-acyloxymethyl phenytoin prodrugs.
Journal of pharmaceutical sciences 1999;88(8):775-9.
1999: Okimoto K; Ohike A; Ibuki R; Aoki O; Ohnishi N; Rajewski R A; Stella V J; Irie T; Uekama K
Factors affecting membrane-controlled drug release for an osmotic pump tablet (OPT) utilizing (SBE)(7m)-beta-CD as both a solubilizer and osmotic agent.
Journal of controlled release : official journal of the Controlled Release Society 1999;60(2-3):311-9.
1999: Okimoto K; Ohike A; Ibuki R; Aoki O; Ohnishi N; Irie T; Uekama K; Rajewski R A; Stella V J
Design and evaluation of an osmotic pump tablet (OPT) for chlorpromazine using (SBE)7m-beta-CD.
Pharmaceutical research 1999;16(4):549-54.
1999: Okimoto K; Rajewski R A; Stella V J
Release of testosterone from an osmotic pump tablet utilizing (SBE)7m-beta-cyclodextrin as both a solubilizing and an osmotic pump agent.
Journal of controlled release : official journal of the Controlled Release Society 1999;58(1):29-38.
1999: Haslam J L; Egodage K L; Chen Y; Rajewski R A; Stella V
Stability of rifabutin in two extemporaneously compounded oral liquids.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 1999;56(4):333-6.
1998: Okimoto K; Miyake M; Ohnishi N; Rajewski R A; Stella V J; Irie T; Uekama K
Design and evaluation of an osmotic pump tablet (OPT) for prednisolone, a poorly water soluble drug, using (SBE)7m-beta-CD.
Pharmaceutical research 1998;15(10):1562-8.
1998: Stella V J; Martodihardjo S; Terada K; Rao V M
Some relationships between the physical properties of various 3-acyloxymethyl prodrugs of phenytoin to structure: potential in vivo performance implications.
Journal of pharmaceutical sciences 1998;87(10):1235-41.
1998: Medlicott N J; Foster K A; Audus K L; Gupta S; Stella V J
Comparison of the effects of potential parenteral vehicles for poorly water soluble anticancer drugs (organic cosolvents and cyclodextrin solutions) on cultured endothelial cells (HUV-EC).
Journal of pharmaceutical sciences 1998;87(9):1138-43.
1998: Georg G I; Ali S M; Stella V J; Waugh W N; Himes R H
Halohydrin analogues of cryptophycin 1: synthesis and biological activity.
Bioorganic & medicinal chemistry letters 1998;8(15):1959-62.
1998: Narisawa S; Stella V J
Increased shelf-life of fosphenytoin: solubilization of a degradant, phenytoin, through complexation with (SBE)7m-beta-CD.
Journal of pharmaceutical sciences 1998;87(8):926-30.
1997: Stella V J; Rajewski R A
Cyclodextrins: their future in drug formulation and delivery.
Pharmaceutical research 1997;14(5):556-67.
1997: Luna E A; Vander Velde D G; Tait R J; Thompson D O; Rajewski R A; Stella V J
Isolation and characterization by NMR spectroscopy of three monosubstituted 4-sulfobutyl ether derivatives of cyclomaltoheptaose (beta-cyclodextrin).
Carbohydrate research 1997;299(3):111-8.
1997: Luna E A; Bornancini E R; Thompson D O; Rajewski R A; Stella V J
Fractionation and characterization of 4-sulfobutyl ether derivatives of cyclomaltoheptaose (beta-cyclodextrin).
Carbohydrate research 1997;299(3):103-10.
1997: Zia V; Rajewski R A; Bornancini E R; Luna E A; Stella V J
Effect of alkyl chain length and degree of substitution on the complexation of sulfoalkyl ether beta-cyclodextrins with steroids.
Journal of pharmaceutical sciences 1997;86(2):220-4.
1997: Kupczyk-Subotkowska L; Tamura K; Pal D; Sakaeda T; Siahaan T J; Stella V J; Borchardt R T
Derivatives of melphalan designed to enhance drug accumulation in cancer cells.
Journal of drug targeting 1997;4(6):359-70.
1996: Gangwar S; Jois S D; Siahaan T J; Vander Velde D G; Stella V J; Borchardt R T
The effect of conformation on membrane permeability of an acyloxyalkoxy-linked cyclic prodrug of a model hexapeptide.
Pharmaceutical research 1996;13(11):1657-62.
1996: Pauletti G M; Gangwar S; Okumu F W; Siahaan T J; Stella V J; Borchardt R T
Esterase-sensitive cyclic prodrugs of peptides: evaluation of an acyloxyalkoxy promoiety in a model hexapeptide.
Pharmaceutical research 1996;13(11):1615-23.
1996: Rajewski R A; Stella V J
Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery.
Journal of pharmaceutical sciences 1996;85(11):1142-69.
1996: Luna E A; Bornancini E R; Tait R J; Thompson D O; Stobaugh J F; Rajewski R A; Stella V J
Evaluation of the utility of capillary electrophoresis for the analysis of sulfobutyl ether beta-cyclodextrin mixtures.
Journal of pharmaceutical and biomedical analysis 1996;15(1):63-71.
1996: Jarho P; Järvinen K; Urtti A; Stella V J; Järvinen T
Modified beta-cyclodextrin (SBE7-beta-CyD) with viscous vehicle improves the ocular delivery and tolerability of pilocarpine prodrug in rabbits.
The Journal of pharmacy and pharmacology 1996;48(3):263-9.
1996: Okimoto K; Rajewski R A; Uekama K; Jona J A; Stella V J
The interaction of charged and uncharged drugs with neutral (HP-beta-CD) and anionically charged (SBE7-beta-CD) beta-cyclodextrins.
Pharmaceutical research 1996;13(2):256-64.
1995: Rajewski R A; Traiger G; Bresnahan J; Jaberaboansari P; Stella V J; Thompson D O
Preliminary safety evaluation of parenterally administered sulfoalkyl ether beta-cyclodextrin derivatives.
Journal of pharmaceutical sciences 1995;84(8):927-32.
1995: Oliyai R; Siahaan T J; Stella V J
The importance of structural factors on the rate and the extent of N,O-acyl migration in cyclic and linear peptides.
Pharmaceutical research 1995;12(3):323-8.
1995: Järvinen T; Järvinen K; Schwarting N; Stella V J
beta-cyclodextrin derivatives, SBE4-beta-CD and HP-beta-CD, increase the oral bioavailability of cinnarizine in beagle dogs.
Journal of pharmaceutical sciences 1995;84(3):295-9.
1995: Shiotani K; Uehata K; Irie T; Uekama K; Thompson D O; Stella V J
Differential effects of sulfate and sulfobutyl ether of beta-cyclodextrin on erythrocyte membranes in vitro.
Pharmaceutical research 1995;12(1):78-84.
1995: Järvinen T; Järvinen K; Urtti A; Thompson D; Stella V J
Sulfobutyl ether beta-cyclodextrin (SBE-beta-CD) in eyedrops improves the tolerability of a topically applied pilocarpine prodrug in rabbits.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 1995;11(2):95-106.
1994: Järvinen K; Järvinen T; Thompson D O; Stella V J
The effect of a modified beta-cyclodextrin, SBE4-beta-CD, on the aqueous stability and ocular absorption of pilocarpine.
Current eye research 1994;13(12):897-905.
1994: Neervannan S; Southard M Z; Stella V J
Dependence of dissolution rate on surface area: is a simple linear relationship valid for co-compressed drug mixtures?
Pharmaceutical research 1994;11(10):1391-5.
1994: Neervannan S; Dias L S; Southard M Z; Stella V J
A convective-diffusion model for dissolution of two non-interacting drug mixtures from co-compressed slabs under laminar hydrodynamic conditions.
Pharmaceutical research 1994;11(9):1288-95.
1994: Bindra D S; Williams T D; Stella V J
Degradation of O6-benzylguanine in aqueous polyethylene glycol 400 (PEG 400) solutions: concerns with formaldehyde in PEG 400.
Pharmaceutical research 1994;11(7):1060-4.
1994: Oliyai R; Safadi M; Meier P G; Hu M K; Rich D H; Stella V J
Kinetics of acid-catalyzed degradation of cyclosporin A and its analogs in aqueous solution.
International journal of peptide and protein research 1994;43(3):239-47.
1993: Scott D O; Bindra D S; Stella V J
Plasma pharmacokinetics of lactone and carboxylate forms of 20(S)-camptothecin in anesthetized rats.
Pharmaceutical research 1993;10(10):1451-7.
1993: Safadi M; Oliyai R; Stella V J
Phosphoryloxymethyl carbamates and carbonates--novel water-soluble prodrugs for amines and hindered alcohols.
Pharmaceutical research 1993;10(9):1350-5.
1993: Kagel J R; Stella V J; Riley C M
A liquid chromatographic method for the determination of the enantiomeric purity of the anticancer drug, 9-amino-20(S)-camptothecin.
Journal of pharmaceutical and biomedical analysis 1993;11(9):793-802.
1993: Kearney A S; Stella V J
Hydrolysis of pharmaceutically relevant phosphate monoester monoanions: correlation to an established structure-reactivity relationship.
Journal of pharmaceutical sciences 1993;82(1):69-72.
1993: Oliyai R; Stella V J
Prodrugs of peptides and proteins for improved formulation and delivery.
Annual review of pharmacology and toxicology 1993;33():521-44.
1992: Sisco J M; Stella V J
An unexpected hydrolysis pH-rate profile, at pH values less than 7, of the labile imide, ICRF-187: (+)-1,2-bis-(3,5-dioxopiperazin-1-yl)propane.
Pharmaceutical research 1992;9(9):1209-14.
1992: Tait R J; Skanchy D J; Thompson D P; Chetwyn N C; Dunshee D A; Rajewski R A; Stella V J; Stobaugh J F
Characterization of sulphoalkyl ether derivatives of beta-cyclodextrin by capillary electrophoresis with indirect UV detection.
Journal of pharmaceutical and biomedical analysis 1992;10(9):615-22.
1992: Sisco J M; Stella V J
Is ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane] unusually reactive for an imide?
Pharmaceutical research 1992;9(8):1076-82.
1992: Fassberg J; Stella V J
A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues.
Journal of pharmaceutical sciences 1992;81(7):676-84.
1992: Oliyai R; Stella V J
Kinetics and mechanism of isomerization of cyclosporin A.
Pharmaceutical research 1992;9(5):617-22.
1992: Kearney A S; Stella V J
The in vitro enzymic labilities of chemically distinct phosphomonoester prodrugs.
Pharmaceutical research 1992;9(4):497-503.
1992: Kearney A S; Stella V J
The anomalous hydrolytic behavior of 1-phenylvinyl phosphate.
Pharmaceutical research 1992;9(3):378-84.
1992: Southard M Z; Green D W; Stella V J; Himmelstein K J
Dissolution of ionizable drugs into unbuffered solution: a comprehensive model for mass transport and reaction in the rotating disk geometry.
Pharmaceutical research 1992;9(1):58-69.
1992: Mathew A E; Mejillano M R; Nath J P; Himes R H; Stella V J
Synthesis and evaluation of some water-soluble prodrugs and derivatives of taxol with antitumor activity.
Journal of medicinal chemistry 1992;35(1):145-51.
1991: Southard M Z; Dias L J; Himmelstein K J; Stella V J
Experimental determinations of diffusion coefficients in dilute aqueous solution using the method of hydrodynamic stability.
Pharmaceutical research 1991;8(12):1489-94.
1991: Waugh W N; Trissel L A; Stella V J
Stability, compatibility, and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containers.
American journal of hospital pharmacy 1991;48(7):1520-4.
1990: al-Razzak L A; Benedetti A E; Waugh W N; Stella V J
Chemical stability of pentostatin (NSC-218321), a cytotoxic and immunosuppressant agent.
Pharmaceutical research 1990;7(5):452-60.
1990: Prankerd R J; Stella V J
The use of oil-in-water emulsions as a vehicle for parenteral drug administration.
Journal of parenteral science and technology : a publication of the Parenteral Drug Association 1990;44(3):139-49.
1990: Richter W F; Chong Y H; Stella V J
On the mechanism of isomerization of cephalosporin esters.
Journal of pharmaceutical sciences 1990;79(2):185-6.
1990: Naringrekar V H; Stella V J
Mechanism of hydrolysis and structure-stability relationship of enaminones as potential prodrugs of model primary amines.
Journal of pharmaceutical sciences 1990;79(2):138-46.
1989: Alvarez F J; Stella V J
Pancreatic lipase-catalyzed hydrolysis of esters of hydroxymethyl phenytoin dissolved in various metabolizable vehicles, dispersed in micellar systems, and in aqueous suspensions.
Pharmaceutical research 1989;6(7):555-63.
1989: Alvarez F J; Stella V J
The role of calcium ions and bile salts on the pancreatic lipase-catalyzed hydrolysis of triglyceride emulsions stabilized with lecithin.
Pharmaceutical research 1989;6(6):449-57.
1987: Paborji M; Waugh W N; Stella V J
Mechanistic investigation of the degradation of sulfamic acid 1,7-heptanediyl ester, an experimental cytotoxic agent, in water and 18oxygen-enriched water.
Journal of pharmaceutical sciences 1987;76(2):161-5.
1985: Aunins J G; Southard M Z; Myers R A; Himmelstein K J; Stella V J
Dissolution of carboxylic acids. III: The effect of polyionizable buffers.
Journal of pharmaceutical sciences 1985;74(12):1305-16.
1984: Stella V J; Mooney K G; Pipkin J D
Dissolution and ionization of warfarin.
Journal of pharmaceutical sciences 1984;73(7):946-8.
1981: Mooney K G; Rodriguez-Gaxiola M; Mintun M; Himmelstein K J; Stella V J
Dissolution kinetics of phenylbutazone.
Journal of pharmaceutical sciences 1981;70(12):1358-65.
1981: Mooney K G; Mintun M A; Himmelstein K J; Stella V J
Dissolution kinetics of carboxylic acids II: effect of buffers.
Journal of pharmaceutical sciences 1981;70(1):22-32.
1981: Mooney K G; Mintun M A; Himmelstein K J; Stella V J
Dissolution kinetics of carboxylic acids I: effect of pH under unbuffered conditions.
Journal of pharmaceutical sciences 1981;70(1):13-22.
1980: Stella V J; Himmelstein K J
Prodrugs and site-specific drug delivery.
Journal of medicinal chemistry 1980;23(12):1275-82.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Valentino Stella

Research Profile (preview)

Chemicals & Drugs

Concepts & Ideas

Phenomena

Procedures

Occupations

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Valentino Stella (preview)

All Publications